The repositioning of the anti-fungal agent ciclopirox olamine as a novel therapeutic agent for the treatment of haematologic malignancy

MLA

Lian G. Rajewski, et al. “The Repositioning of the Anti-Fungal Agent Ciclopirox Olamine as a Novel Therapeutic Agent for the Treatment of Haematologic Malignancy.” Journal of Clinical Pharmacy and Therapeutics, vol. 36, Aug. 2010, pp. 128–34. EBSCOhost, https://doi.org/10.1111/j.1365-2710.2010.01172.x.

APA

Lian G. Rajewski, K. Castle, Lavonne Patton, Aaron D. Schimmer, Scott Weir, & Jim Kasper. (2010). The repositioning of the anti-fungal agent ciclopirox olamine as a novel therapeutic agent for the treatment of haematologic malignancy. Journal of Clinical Pharmacy and Therapeutics, 36, 128–134. https://doi.org/10.1111/j.1365-2710.2010.01172.x

Chicago

Lian G. Rajewski, K. Castle, Lavonne Patton, Aaron D. Schimmer, Scott Weir, and Jim Kasper. 2010. “The Repositioning of the Anti-Fungal Agent Ciclopirox Olamine as a Novel Therapeutic Agent for the Treatment of Haematologic Malignancy.” Journal of Clinical Pharmacy and Therapeutics 36 (August): 128–34. doi:10.1111/j.1365-2710.2010.01172.x.